Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afstyla in pediatric severe hemophilia A
NCT02093897Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Mar 2014
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 3 trial of lonoctocog alfa in hemophilia A, sponsored by CSL Limited. Started Mar 2014; status: completed.
02
Drugs
lonoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02093897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093897.